Karin Jacobson is Science Engagement Director at Japan Tobacco International (JTI) and based in Geneva, Switzerland. In her role, Karin leads scientific engagement activities, develops external scientific messaging and drives understanding of tobacco and nicotine product science. Prior to joining JTI in 2017, Karin built extensive experience in pharmaceutical science. She worked as a research scientist in pharmacology at the University of Geneva and in the biotechnology company NovImmune before transitioning to the consulting company NeuroAssets, specialized in neuroscience. As a senior consultant, she provided expertise and guidance on research strategy, preclinical study design and scientific communication. Originally from Sweden, Karin holds a PhD in Pharmaceutical Science from the University of Basel, Switzerland.

R. Emma, PhD in Translational Biomedicine, is assistant professor of Internal Medicine at the Department of Clinical and Experimental Medicine of the University of Catania. She is also a researcher of the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) of the University of Catania. Her research activity deals with respiratory diseases, harm of cigarette smoking and health benefits of quitting. She has experience in toxicological in vitro studies and in exposure methods to smoke/aerosol using automated instruments (smoking/vaping machines).

Konstantinos Farsalinos, MD, MPH, is a physician and senior researcher specialising in Public Health at the Universities of Patras and West Attica in Greece. He has conducted extensive research on smoking, tobacco harm reduction, and vaping since 2011, publishing over 90 studies and articles. Notably, he authored the first systematic review on the safety and risk profile of e-cigarettes in 2014; his research was influential in shaping the EU’s regulatory framework on vaping. In 2020, he was recognized as a Highly Cited Researcher for his significant impact in global science. During the pandemic, he published studies exploring the relationship between smoking, nicotine, and COVID-19.

Anna Masser works as a Scientific Writer in the Product Science group at Swedish Match. In this role, Anna focuses on scientific publishing as well as aiming to make the company’s science understandable for everyone. She holds a PhD in Molecular Biosciences from Stockholm University, where her research centered on understanding how cells regulate protein homeostasis.

Elaine Round is currently Group Head of Life Science at BAT, based in Southampton, U.K.. She’s responsible for BAT’s global science programme for New Category products, and the global science engagement plan. Prior to her current role, Elaine was the global head of toxicology at BAT where she has led the team responsible for safety assessments across product categories.